<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000513078">
  <TermName>Innohep</TermName>
  <TermPronunciation>(IH-noh-HEP)</TermPronunciation>
  <TermDefinition>
    <DefinitionText>A drug that is used with another drug, warfarin, to treat blood clots that form deep in the veins and to prevent new blood clots from forming. It is a type of anticoagulant. Also called tinzaparin sodium.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <MediaLink ref="CDR0000718492" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Innohep&quot;" language="en" id="_3"/>
  <MediaLink ref="CDR0000718491" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Innohep&quot;" language="es" id="_4"/>
  <SpanishTermName>Innohep</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>Medicamento que se usa con otro medicamento llamado warfarina, para tratar los coágulos de sangre que se forman en lo profundo de las venas y para prevenir que se formen nuevos coágulos de sangre. Es un tipo de anticoagulante. También se llama tinzaparina sódica.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
  <DateFirstPublished>2006-10-21</DateFirstPublished>
  <DateLastModified>2007-06-18</DateLastModified>
</GlossaryTerm>
